Cargando…

A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)

Society is burdened with the uncontrolled use of alcohol, an ongoing issue, with a substantial associated morbidity and a pressing economical reverberation. It is inevitable that a series of psychiatric patients who display alcohol disorders will be admitted to hospital while also suffering from hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Trifu, Simona, Țîbîrnă, Andrian, Costea, Radu-Virgil, Popescu, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851668/
https://www.ncbi.nlm.nih.gov/pubmed/33603878
http://dx.doi.org/10.3892/etm.2021.9702
_version_ 1783645674337730560
author Trifu, Simona
Țîbîrnă, Andrian
Costea, Radu-Virgil
Popescu, Alexandra
author_facet Trifu, Simona
Țîbîrnă, Andrian
Costea, Radu-Virgil
Popescu, Alexandra
author_sort Trifu, Simona
collection PubMed
description Society is burdened with the uncontrolled use of alcohol, an ongoing issue, with a substantial associated morbidity and a pressing economical reverberation. It is inevitable that a series of psychiatric patients who display alcohol disorders will be admitted to hospital while also suffering from health conditions, such as liver disease, due to the consumption of alcohol. Managing comorbid patients in a psychiatric facility is a delicate matter that requires a collaborative team. The aim of this systematic paper is to highlight the following: The possibility of treating alcohol use disorder (AUD) and alcohol withdrawal syndrome (AWS) overlapping alcohol liver disease (ALD) within a psychiatric institution, and the importance of a collaborative multidisciplinary team; correctly dosing psychoactive medication when metabolism is affected by ALD; deciding when is it necessary to seek a transfer to a general hospital. Prescribing medication in patients suffering from ALD is still a not a fully documented territory. Protein binding, metabolism, bioavailability, extraction ratios, excretion route, and half-life must be taken into consideration as well as frequently repeating liver panels. Studies suggest that short-acting benzodiazepines are preferred over their alternatives when treating AWS in ALD. All anticonvulsants can be used in patients with decompensated liver disease with caution, although newer generation antiepileptic agents should be first line. Propofol is favored to benzodiazepines or opioids in the case of decompensated cirrhosis. Patients with ALD are likely to be further compromised by the potential hepatocytotoxicity of some pharmacological agents. On that account, having an integrated perspective of the medical case while taking into consideration the underlying illness as well as possible drug interaction is crucial in treating AUD or AWS in a psychiatric institution.
format Online
Article
Text
id pubmed-7851668
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-78516682021-02-17 A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review) Trifu, Simona Țîbîrnă, Andrian Costea, Radu-Virgil Popescu, Alexandra Exp Ther Med Review Society is burdened with the uncontrolled use of alcohol, an ongoing issue, with a substantial associated morbidity and a pressing economical reverberation. It is inevitable that a series of psychiatric patients who display alcohol disorders will be admitted to hospital while also suffering from health conditions, such as liver disease, due to the consumption of alcohol. Managing comorbid patients in a psychiatric facility is a delicate matter that requires a collaborative team. The aim of this systematic paper is to highlight the following: The possibility of treating alcohol use disorder (AUD) and alcohol withdrawal syndrome (AWS) overlapping alcohol liver disease (ALD) within a psychiatric institution, and the importance of a collaborative multidisciplinary team; correctly dosing psychoactive medication when metabolism is affected by ALD; deciding when is it necessary to seek a transfer to a general hospital. Prescribing medication in patients suffering from ALD is still a not a fully documented territory. Protein binding, metabolism, bioavailability, extraction ratios, excretion route, and half-life must be taken into consideration as well as frequently repeating liver panels. Studies suggest that short-acting benzodiazepines are preferred over their alternatives when treating AWS in ALD. All anticonvulsants can be used in patients with decompensated liver disease with caution, although newer generation antiepileptic agents should be first line. Propofol is favored to benzodiazepines or opioids in the case of decompensated cirrhosis. Patients with ALD are likely to be further compromised by the potential hepatocytotoxicity of some pharmacological agents. On that account, having an integrated perspective of the medical case while taking into consideration the underlying illness as well as possible drug interaction is crucial in treating AUD or AWS in a psychiatric institution. D.A. Spandidos 2021-03 2021-01-25 /pmc/articles/PMC7851668/ /pubmed/33603878 http://dx.doi.org/10.3892/etm.2021.9702 Text en Copyright: © Trifu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Trifu, Simona
Țîbîrnă, Andrian
Costea, Radu-Virgil
Popescu, Alexandra
A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title_full A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title_fullStr A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title_full_unstemmed A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title_short A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review)
title_sort multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851668/
https://www.ncbi.nlm.nih.gov/pubmed/33603878
http://dx.doi.org/10.3892/etm.2021.9702
work_keys_str_mv AT trifusimona amultidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT tibirnaandrian amultidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT costearaduvirgil amultidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT popescualexandra amultidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT trifusimona multidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT tibirnaandrian multidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT costearaduvirgil multidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview
AT popescualexandra multidisciplinaryapproachtothemanagementofliverdiseaseandalcoholdisordersinpsychiatricsettingsreview